Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (71-80 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is NeededAlberto Dalla Volta, Deborah Cosentini, Alessandro Antonelli, et al.
The Oncologist|November 11, 2008
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questionsAlfredo Berruti, Maria Pia Brizzi, Daniele Generali, et al.
ESMO Open|March 30, 2020
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinionDaniele Santini, Alfredo Berruti, Massimo Di Maio, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 2008
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patientsPiero Borasio, Alfredo Berruti, Andrea Billé, et al.
Future Oncology (London, England)|September 26, 2015
Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?Vito Amoroso, Fausto Petrelli, Rebecca Pedersini, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patientsAlfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Open Access Journal of Urology|November 8, 2013
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzleAlfredo Berruti, Francesca Vignani, Lucianna Russo, et al.
Hormones & Cancer|October 6, 2011
Metronomic therapy concepts in the management of adrenocortical carcinomaAlfredo Berruti, Paola Sperone, Elisa Bellini, et al.
Frontiers in Immunology|October 7, 2021
Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic ReviewFausto Petrelli, Francesca Consoli, Antonio Ghidini, et al.
Pageof 38

Showing results (71-80 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is NeededAlberto Dalla Volta, Deborah Cosentini, Alessandro Antonelli, et al.
The Oncologist|November 11, 2008
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questionsAlfredo Berruti, Maria Pia Brizzi, Daniele Generali, et al.
ESMO Open|March 30, 2020
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinionDaniele Santini, Alfredo Berruti, Massimo Di Maio, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 2008
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patientsPiero Borasio, Alfredo Berruti, Andrea Billé, et al.
Future Oncology (London, England)|September 26, 2015
Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?Vito Amoroso, Fausto Petrelli, Rebecca Pedersini, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patientsAlfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Open Access Journal of Urology|November 8, 2013
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzleAlfredo Berruti, Francesca Vignani, Lucianna Russo, et al.
Hormones & Cancer|October 6, 2011
Metronomic therapy concepts in the management of adrenocortical carcinomaAlfredo Berruti, Paola Sperone, Elisa Bellini, et al.
Frontiers in Immunology|October 7, 2021
Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic ReviewFausto Petrelli, Francesca Consoli, Antonio Ghidini, et al.
Pageof 38